Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, The First Hospital, and Institute of Immunology, Jilin University, Changchun, China; Columbia Center for Translational Immunology, Columbia University Medical Center, New York, United States
Yan Wu
Columbia Center for Translational Immunology, Columbia University Medical Center, New York, United States
Elena A Federzoni
Lung Biotechnology PBC, Silver Spring, United States
Xiaodan Wang
Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, The First Hospital, and Institute of Immunology, Jilin University, Changchun, China
Andre Dharmawan
Lung Biotechnology PBC, Silver Spring, United States
Xiaoyi Hu
Columbia Center for Translational Immunology, Columbia University Medical Center, New York, United States
Hui Wang
Columbia Center for Translational Immunology, Columbia University Medical Center, New York, United States
Robert J Hawley
Columbia Center for Translational Immunology, Columbia University Medical Center, New York, United States
Sean Stevens
Lung Biotechnology PBC, Silver Spring, United States
Megan Sykes
Columbia Center for Translational Immunology, Columbia University Medical Center, New York, United States
Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, The First Hospital, and Institute of Immunology, Jilin University, Changchun, China; International Center of Future Science, Jilin University, Changchun, China
Transgenic CD47 overexpression is an encouraging approach to ameliorating xenograft rejection and alloresponses to pluripotent stem cells, and the efficacy correlates with the level of CD47 expression. However, CD47, upon ligation, also transmits signals leading to cell dysfunction or death, raising a concern that overexpressing CD47 could be harmful. Here, we unveiled an alternative source of cell surface CD47. We showed that extracellular vesicles, including exosomes, released from normal or tumor cells overexpressing CD47 (transgenic or native) can induce efficient CD47 cross-dressing on pig or human cells. Like the autogenous CD47, CD47 cross-dressed on cell surfaces is capable of interacting with SIRPα to inhibit phagocytosis. However, ligation of the autogenous, but not cross-dressed, CD47 induced cell death. Thus, CD47 cross-dressing provides an alternative source of cell surface CD47 that may elicit its anti-phagocytic function without transmitting harmful signals to the cells. CD47 cross-dressing also suggests a previously unidentified mechanism for tumor-induced immunosuppression. Our findings should help to further optimize the CD47 transgenic approach that may improve outcomes by minimizing the harmful effects of CD47 overexpression.